罗提古丁贴片对莱沃多巴 (L-Dopa) 诱导的呼吸障碍有效:一个病例报告
Koji Hayashi1, Yuka Nakaya1, Koichi Kimura1
1Department of Rehabilitation Medicine, Fukui General Hospital, Fukui, JPN.
对帕金森病的乐伏多巴治疗可能会导致呼吸系统问题,如呼吸不良. 在一项患者病例研究中,切换到罗提古丁有效地解决了这些症状,并改善了运动功能.
科学领域:
- 神经学 神经学
- 药理学 药理学是指药理学的学科.
背景情况:
- 帕金森病 (PD) 是一种进展性神经退行性疾病,患病率正在上升.
- 运动症状如运动和平衡障碍是众所周知的,但呼吸道并发症,特别是与勒沃多巴 (L-dopa) 治疗相关的呼吸障碍,是不太知名的.
更多相关视频
06:45Rating L-DOPA-Induced Dyskinesias in the Unilaterally 6-OHDA-Lesioned Rat Model of Parkinson's Disease
Published on: October 4, 2021
07:58Methods to Characterize Spontaneous and Startle-induced Locomotion in a Rotenone-induced Parkinson's Disease Model of Drosophila
Published on: August 17, 2014
相关概念视频
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
COPD: Management Using Bronchodilators and Corticosteroids
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
Direct-Acting Cholinergic Agonists: Therapeutic Uses
